Evaluation of screening and treatment of cryptococcal antigenaemia among HIV-infected persons in Soweto, South Africa. - Wikidata - wikimedia - TriplyDB

Evaluation of screening and treatment of cryptococcal antigenaemia among HIV-infected persons in Soweto, South Africa.

Evaluation of screening and treatment of cryptococcal antigenaemia among HIV-infected persons in Soweto, South Africa.

http://www.wikidata.org/entity/Q39030373

about

LATERAL FLOW ASSAY FOR CRYPTOCOCCAL ANTIGEN: AN IMPORTANT ADVANCE TO IMPROVE THE CONTINUUM OF HIV CARE AND REDUCE CRYPTOCOCCAL MENINGITIS-RELATED MORTALITY Screening HIV-Infected Patients with Low CD4 Counts for Cryptococcal Antigenemia prior to Initiation of Antiretroviral Therapy: Cost Effectiveness of Alternative Screening Strategies in South Africa Prevalence and Hospital Management of Amphotericin B Deoxycholate-Related Toxicities during Treatment of HIV-Associated Cryptococcal Meningitis in South Africa Cost-effectiveness of CRAG-LFA screening for cryptococcal meningitis among people living with HIV in Uganda.Cryptococcal Antigen Screening in Patients Initiating ART in South Africa: A Prospective Cohort Study Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis.HIV-Associated Cryptococcal Disease in Resource-Limited Settings: A Case for "Prevention Is Better Than Cure"?Preemptive Therapy for Cryptococcal Meningitis: A Valid Strategy for Latin America?CD4 Cell Count Threshold for Cryptococcal Antigen Screening of HIV-Infected Individuals: A Systematic Review and Meta-analysis.A qualitative evaluation of an implementation study for cryptococcal antigen screening and treatment in Uganda A Prospective Evaluation of a Multisite Cryptococcal Screening and Treatment Program in HIV Clinics in Uganda An audit of the screen-and-treat intervention to reduce cryptococcal meningitis in HIV-positive patients with low CD4 count

P2860

Q26783210-3363D305-E05C-4D8E-9746-10DAA59D0C8B Q36070803-6CEEE332-033E-4196-B780-CA1D120279BD Q36088679-A6D271CE-3596-407B-ABB8-4871C1E2F135 Q36321037-E4DB1297-434B-4684-8C5C-620A7DAD4066 Q36543833-51E88681-17E9-4F36-8E4E-A93EFFA107D5 Q39379643-19D88C9B-F2ED-4FB7-981F-0C3CD49AED73 Q47646979-D3670981-DA20-4987-9816-FF016184550D Q48520662-F34B9C50-5391-4949-9955-47210D50290F Q51365549-CFA1CA64-6B8B-4A4F-B7A4-77C89AC7FFDB Q56910972-CAE9A1F5-ED0B-44E6-90BE-F7F57E94E5D5 Q56912008-DB98D546-5D75-4656-9D90-5C77203A50CF Q58794920-956D4F9F-9447-4E2C-87FE-A3874EEE2440

P2860

Evaluation of screening and treatment of cryptococcal antigenaemia among HIV-infected persons in Soweto, South Africa.

http://www.wikidata.org/entity/Q39030373

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Evaluation of screening and tr ...... rsons in Soweto, South Africa.

@en

Evaluation of screening and tr ...... rsons in Soweto, South Africa.

@nl

type

label

Evaluation of screening and tr ...... rsons in Soweto, South Africa.

@en

Evaluation of screening and tr ...... rsons in Soweto, South Africa.

@nl

prefLabel

Evaluation of screening and tr ...... rsons in Soweto, South Africa.

@en

Evaluation of screening and tr ...... rsons in Soweto, South Africa.

@nl

P1433

Q39030373-69E8C309-A47C-4FBB-B518-5C628C8EF7CF

P1476

Q39030373-EB93AB90-75E2-4CDC-86F1-AD025BCCC708

P2093

Q39030373-2332C4DA-F481-4941-86B0-5E77BA4F515D

Q39030373-6170C601-0E9C-4CB2-B984-330104213773

Q39030373-67746B5B-B327-4109-B2E9-EDFB2C25960C

Q39030373-94C74F98-0477-43B1-92F2-2831881BCC9E

Q39030373-A469DEAC-A51A-40D6-ABF2-D3545E48CDCD

Q39030373-F92D9195-8A88-4E6C-A746-233E6E7DACDD

P2860

Q39030373-26684797-0C9D-4573-BB40-74122F1AE208

Q39030373-33179239-3095-4AE1-8AB4-0407A97D9291

Q39030373-39CA9A79-4396-43C6-AAE5-AE7CC8E1C7F5

Q39030373-553FBCCD-B2D5-461A-8837-38912D9CA416

Q39030373-5B041FB0-F76D-40A0-9AD1-D5849B0D775B

Q39030373-5CED9883-4162-49B8-B72E-85A173A6103F

Q39030373-602A5D56-CF49-40A7-940A-248D96E62E75

Q39030373-7266CBFC-1E24-4FA0-905C-71A193394641

Q39030373-797359E3-60B6-41BE-8298-5A2A6F44FFC5

Q39030373-80F36A4A-A938-487C-99AE-B6DFFEF60F3E

P304

Q39030373-3EEB5C84-595D-438D-B126-3C72BCA5AD72

P31

Q39030373-7FD2035C-71B5-4D0F-8A8E-F23F7FD2B61E

P356

Q39030373-A32A0B54-A969-433F-A2D6-DC279B370796

P433

Q39030373-B3E4F962-DE0C-420E-A0DF-2EA1112F8234

P478

Q39030373-8B27348B-BE33-40DA-8912-96F339267FCA

P577

Q39030373-ADB7BEC6-74B1-4F3D-9F9C-E3E1B111B0C3

P698

Q39030373-86450182-53E7-4FBA-9AEF-AB6DC5016DF8

P921

Q39030373-80160E54-B0BC-4A71-9A16-E0C0B6037453

P356

P1433

P1476

Evaluation of screening and tr ...... rsons in Soweto, South Africa.

@en

P2093

A S Karstaedt

http://www.w3.org/2001/XMLSchema#string

J F Mendes

http://www.w3.org/2001/XMLSchema#string

M Roy

http://www.w3.org/2001/XMLSchema#string

N P Govender

http://www.w3.org/2001/XMLSchema#string

T G Zulu

http://www.w3.org/2001/XMLSchema#string

T M Chiller

http://www.w3.org/2001/XMLSchema#string

P2860

Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/microL who start HIV therapy in resource-limited settings

Integrating cryptococcal antigen screening and pre-emptive treatment into routine HIV care

Cost effectiveness of cryptococcal antigen screening as a strategy to prevent HIV-associated cryptococcal meningitis in South Africa

Adult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected cases

Long term outcomes of antiretroviral therapy in a large HIV/AIDS care clinic in urban South Africa: a prospective cohort study.

Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa.

Early mortality in adults initiating antiretroviral therapy (ART) in low- and middle-income countries (LMIC): a systematic review and meta-analysis

Clinical utility of the cryptococcal antigen lateral flow assay in a diagnostic mycology laboratory.

Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates obtained through population-based surveillance in South Africa in 2002-2003 and 2007-2008.

Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitis

P304

468-476

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/HIV.12245

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2015-02-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25689352

http://www.w3.org/2001/XMLSchema#string

P921

Aafrikaa Kibbaa